Amanote Research

Amanote Research

    RegisterSign In

Refractory Myasthenia Gravis – Patient Burden and the Need for New Therapeutic Targets

European Neurological Review - United Kingdom
doi 10.17925/enr.2018.13.1.18
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

January 1, 2018

Authors
Saiju Jacob
Publisher

Touch Medical Media, Ltd.


Related search

Understanding the Burden of Refractory Myasthenia Gravis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2019English

New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis

Journal of Neuromuscular Diseases
Neurology
2018English

Treatment for Refractory Myasthenia Gravis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1989English

Refractory Myasthenia Gravis: Clinical Description and Literature Review

Scholars Journal of Applied Medical Sciences
2020English

Escalation Strategies in the Treatment of Refractory Myasthenia Gravis

Neurology International Open
2018English

Employment in Refractory Myasthenia Gravis: An Mgfa Registry Analysis

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2019English

Myasthenia Gravis

CMAJ
Medicine
2018English

Thymectomy for Myasthenia Gravis

Southern Medical Journal
Medicine
1960English

Long-Term Treatment of Refractory Myasthenia Gravis With Subcutaneous Immunoglobulin

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy